Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07219498 · ClinicalTrials.gov registry record · NA
Effects of a 5-Week Probiotic Supplementation Intervention on Markers of Delayed Onset Muscle Soreness
A NA study of Delayed Onset Muscle Soreness (DOMS) and Exercise Induced Muscle Damage, sponsored by University of Minnesota.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT07219498: Recruiting NA study of Delayed Onset Muscle Soreness (DOMS) and Exercise Induced Muscle Damage, sponsored by University of Minnesota.
NCT07219498 is a NA study of Delayed Onset Muscle Soreness (DOMS) and Exercise Induced Muscle Damage that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07219498, a NA study of Delayed Onset Muscle Soreness (DOMS) and Exercise Induced Muscle Damage, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate how probiotic supplementation (PS) influences post-exercise recovery in healthy, physically active young adults. Researchers aim to determine if the Lactobacillus casei probiotic strain reduces symptoms of delayed onset muscle soreness (DOMS) based on perceived muscle soreness, pressure pain threshold, and power output following exercise induced muscle damage (EIMD).
Primary Outcome
Visual Analog Scale for perceived muscle soreness Each number on the scale will be designated with a descriptive word that corresponds to the soreness level they are experiencing. The scale will be laid out in order of increasing muscle soreness with "1" representing no pain.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Lactobacillus casei
- OTHER Placebo Capsule(s)
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2026-02-05 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What NCT07219498 shows while recruiting
NCT07219498 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Delayed Onset Muscle Soreness (DOMS) appearing as the primary indexed condition, and to 2 interventions - of which Lactobacillus casei is the first listed.
NCT07219498 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT07219498 about?
NCT07219498 is a clinical study titled "Effects of a 5-Week Probiotic Supplementation Intervention on Markers of Delayed Onset Muscle Soreness". The purpose of this study is to evaluate how probiotic supplementation (PS) influences post-exercise recovery in healthy, physically active young adults. Researchers aim to determine if the Lactobacillus casei probiotic strain reduces symptoms of delayed onset muscle soreness (DOMS) based on perceiv...
What is the current status of trial NCT07219498?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2026-02-05. Estimated completion is 2026-04-30.
What conditions does trial NCT07219498 study?
This clinical trial studies the following conditions: Delayed Onset Muscle Soreness (DOMS), Exercise Induced Muscle Damage.
What interventions are being tested in trial NCT07219498?
The interventions under investigation include: Lactobacillus casei (DIETARY_SUPPLEMENT), Placebo Capsule(s) (OTHER).
Who is sponsoring clinical trial NCT07219498?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07219498 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Delayed Onset Muscle Soreness (DOMS)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07219498's enrollment target sits among peer trials
24 1737th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI